Neurobiology of schizophrenia: from outcome to pathophysiological insights.
作者信息
Falkai P, Möller H-J
出版信息
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):93-4. doi: 10.1007/s00406-012-0294-y.
Abstract
摘要
相似文献
1
Neurobiology of schizophrenia: from outcome to pathophysiological insights.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):93-4. doi: 10.1007/s00406-012-0294-y.
2
Cognitive experimental approaches to investigating impaired cognition in schizophrenia: a paradigm shift.
J Clin Exp Neuropsychol. 2002 Oct;24(7):873-82. doi: 10.1076/jcen.24.7.873.8386.
3
Neurobiology and phenotypic expression in early onset schizophrenia.
Early Interv Psychiatry. 2011 Feb;5(1):3-14. doi: 10.1111/j.1751-7893.2010.00253.x.
4
Cognitive impairment in schizophrenia: profile, course, and neurobiological determinants.
Handb Clin Neurol. 2012;106:433-45. doi: 10.1016/B978-0-444-52002-9.00025-5.
5
The neuropsychology and neurobiology of late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: A critical review.
Neurosci Biobehav Rev. 2017 Dec;83:604-621. doi: 10.1016/j.neubiorev.2017.08.024. Epub 2017 Sep 1.
6
[First conference. Neurobiology of schizophrenia].
Vertex. 2002;13 Suppl:5-15.
7
Phenomenology and neurobiology of self disorder in schizophrenia: Primary factors.
Schizophr Res. 2015 Dec;169(1-3):464-473. doi: 10.1016/j.schres.2015.09.024. Epub 2015 Oct 26.
8
Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.
Schizophr Res. 2004 Dec 15;72(1):5-9. doi: 10.1016/j.schres.2004.09.010.
9
The molecular and cellular neurobiology of nicotine abuse in schizophrenia.
Pharmacopsychiatry. 2008 Sep;41 Suppl 1:S51-9. doi: 10.1055/s-2008-1081463.
10
Where will insights into hippocampal activity in schizophrenia lead us?
Expert Rev Neurother. 2010 Jan;10(1):1-4. doi: 10.1586/ern.09.145.
引用本文的文献
1
A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophrenia.
PLoS One. 2017 Dec 8;12(12):e0189348. doi: 10.1371/journal.pone.0189348. eCollection 2017.
2
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy.
Biomed Res Int. 2015;2015:484963. doi: 10.1155/2015/484963. Epub 2015 Sep 27.
本文引用的文献
1
A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):117-24. doi: 10.1007/s00406-011-0233-3. Epub 2011 Sep 7.
2
Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE).
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):139-49. doi: 10.1007/s00406-011-0220-8. Epub 2011 Aug 2.
3
General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):107-15. doi: 10.1007/s00406-011-0224-4. Epub 2011 Jul 27.
4
Critical trial-related criteria in acute schizophrenia studies.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):151-5. doi: 10.1007/s00406-011-0225-3. Epub 2011 Jul 26.
5
Investigation of schizophrenic patients from Istanbul, Turkey for the presence of West Nile virus.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):173-7. doi: 10.1007/s00406-011-0222-6. Epub 2011 Jul 2.
6
Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):131-8. doi: 10.1007/s00406-011-0219-1. Epub 2011 May 28.
7
Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):95-105. doi: 10.1007/s00406-011-0218-2. Epub 2011 May 26.
8
Differential expression of HINT1 in schizophrenia brain tissue.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):167-72. doi: 10.1007/s00406-011-0216-4. Epub 2011 May 8.
9
Caregiver burden in chronic mental illness: the role of patient and caregiver characteristics.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):157-66. doi: 10.1007/s00406-011-0215-5. Epub 2011 May 3.
10
Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):125-30. doi: 10.1007/s00406-011-0213-7. Epub 2011 Apr 22.
Zotero 插件